Q
QuantAbundanceAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

29,772 signal articles · 75 in last 24h · 148,324 total before filter · latest 1h ago
75last 24h
977last 7d
110● bullish (7d)
126● bearish (7d)
212publishers
AllMacro369Earnings115M&A98Regulatory8Product11Analyst12
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Firefly Aerospace (FLY) Stock May Be Overvalued Following Its Sweden Launch Deal
Simply Wall St.4h agoneutral
Firefly Aerospace (FLY) Stock May Be Overvalued Following Its Sweden Launch Deal

Firefly Aerospace has seen its share price fall sharply over the past year, which puts a spotlight on a basic question. Is the current US$20.97 price tag still in line with what the business is generating in sales? The stock has declined 53.6% over the past year, which raises fresh doubts about how much investors are willing to pay for each dollar of revenue. A new multi-launch agreement for Alpha rockets from Sweden’s Esrange Space Center, along with radar work tied to the U.S. Space Force,...

Is Recursion Pharmaceuticals (RXRX) A Bargain As Its Shares Rebound?
Simply Wall St.4h agoneutral
Is Recursion Pharmaceuticals (RXRX) A Bargain As Its Shares Rebound?

Recursion Pharmaceuticals (RXRX) is back on traders’ screens after a sharp daily move, with the share price closing at US$3.83. Recent returns have been mixed over the past week and month. For context, Recursion Pharmaceuticals has delivered an 8.19% 1-day share price return and a 19.69% 7-day share price return, yet the total shareholder return over the past year is down 22%. This hints at short-term momentum building against a more difficult long-term backdrop and shifting views on the...

XPeng (XPEV) Stock Sees Fair Value Falls As Analysts Split On Growth And Execution
Simply Wall St.4h agobearish
XPeng (XPEV) Stock Sees Fair Value Falls As Analysts Split On Growth And Execution

XPeng’s central valuation estimate has been reset, with Fair Value moving from US$22.36 to US$19.06. This change reframes how investors may think about potential upside in the stock. The wide spread in updated Street targets, now roughly between US$12 and US$24, reflects differing views on XPeng’s ability to balance growth plans, robotics optionality and the execution questions raised in recent research. As you read on, you will see how to track these shifting assumptions and follow the...

Could IonQ (IONQ) AI Written Quantum Circuits Unlock More Real World Workloads?
Simply Wall St.4h agoneutral
Could IonQ (IONQ) AI Written Quantum Circuits Unlock More Real World Workloads?

IonQ (NYSE: IONQ) and partners Oak Ridge National Laboratory, NVIDIA, and the University of Tennessee built a generative AI system that writes quantum optimization circuits. The joint team reports that the AI driven circuit synthesis cuts out manual trial and error tuning for complex quantum optimization tasks. The research, benchmarked at scale, received a best paper award at a major industry conference, signaling peer recognition of its impact. This new generative AI circuit writer is only...

Bill Ackman's Pershing Square IPO Breaks Out
Investor's Business Daily5h agoneutral
Bill Ackman's Pershing Square IPO Breaks Out

Bill Ackman's Pershing Square Inc., a recent IPO, broke out past a buy point Friday in a rocky market.  The hedge fund billionaire's publicly traded investment vehicle, Pershing Square Inc., rallied an impressive 27% for the week after bullish analyst upgrades.

Nestlé Loses the Keys to Its Russian Business
Moby5h agoneutral
Nestlé Loses the Keys to Its Russian Business

The food giant fell after Moscow placed its local operations under temporary external administration, reviving fears that another Western company could ultimately lose control of its Russian assets.

Capital Economics Warns AI Bubble Collapse Could Trigger 30% US Stock Market Decline
InvestorsHub5h agoneutral
Capital Economics Warns AI Bubble Collapse Could Trigger 30% US Stock Market Decline

Capital Economics has outlined the potential consequences of a collapse in artificial intelligence-related stock valuations, forecasting substantial declines in global equities, limited gains in some government bonds and a weaker US dollar. In a note published this week, chief economic adviser John Higgins said he sees “plenty of signs that we are now in the late stages of a bubble in AI,” identifying the US equity market as the primary source of potential disruption.

Fortinet (FTNT) Stock Could Be 22% Overvalued On New York Hub Opening
Simply Wall St.5h agoneutral
Fortinet (FTNT) Stock Could Be 22% Overvalued On New York Hub Opening

Fortinet has ridden a powerful share price run in recent years, which puts a sharp spotlight on whether the current US$169.84 level is adequately supported by the cash the business can generate. With expectations shaped by both strong historical returns and fresh corporate milestones, the question now is how the stock lines up against its own cash flow potential. Over the past 3 years the stock has returned 191.6%. This raises the stakes on whether that performance is reflected in the...

Aptiv (APTV) Stock Fair Value Falls As Analysts Split On Growth And Execution
Simply Wall St.5h agobearish
Aptiv (APTV) Stock Fair Value Falls As Analysts Split On Growth And Execution

Aptiv’s fair value estimate has moved from US$78.21 to US$66.61, pointing to a reduced assessed upside compared with earlier models. This shift lines up with a split analyst narrative, where optimism around the post EDS separation mix and software exposure is balanced against caution on auto sector headwinds, execution questions and softer guidance. Read on to see how these views are shaping the evolving story around Aptiv and what to watch as new data comes through. Stay updated as the Fair...

Hubbell (HUBB) Faces A Valuation Test As Morgan Stanley Conference Puts Growth In Focus
Simply Wall St.5h agoneutral
Hubbell (HUBB) Faces A Valuation Test As Morgan Stanley Conference Puts Growth In Focus

Conference spotlight and why Hubbell is back on investor radar Hubbell (HUBB) steps into the spotlight as President and CEO Gerben W. Bakker speaks at Morgan Stanley's Laguna Conference. The appearance gives investors fresh commentary to measure against recent share performance. Recent trading tells a mixed story. Hubbell’s share price has eased over the past month, with a 30 day share price return of 6.04% in the red. By contrast, the 1 year total shareholder return of 2.48% and the 5 year...

Vicor (VICR) Is Up 12.5% After Licensing Its AI Power Technology Is The Bull Case Changing?
Simply Wall St.5h agoneutral
Vicor (VICR) Is Up 12.5% After Licensing Its AI Power Technology Is The Bull Case Changing?

Earlier this month, Vicor Corporation granted a non-exclusive license to a leading AI original equipment manufacturer for its patented Vertical Power Delivery (VPD) technology, allowing the OEM to source VPD modules from both Vicor and unlicensed suppliers. This licensing approach, combined with Vicor’s patented VPD architecture that tackles the “last inch problem” in powering high-performance AI processors, could materially influence how hyperscalers structure their power-delivery supply...

Tempus AI (TEM) Unveils Whole Genome Platform With Plans For 1 Million Genomes
Simply Wall St.5h agoneutral
Tempus AI (TEM) Unveils Whole Genome Platform With Plans For 1 Million Genomes

Tempus AI (NasdaqGS:TEM) announced a new whole-genome sequencing initiative linked to clinical data for AI research in September 2026. The project aims to create a de-identified multimodal dataset that connects full genome reads with real-world clinical and imaging records. Management targets scaling the platform to one million whole genomes tied to patient outcomes for use in drug development and personalized care. This new whole-genome sequencing and clinical data platform comes against a...